Corcept Therapeutics Inc (NASDAQ:CORT)

6.12
Delayed Data
As of May 29
 +0.23 / +3.90%
Today’s Change
2.08
Today|||52-Week Range
6.65
+104.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues5.9M7.3M9.0M10.1M
 
 
 
 
 
Cost of Goods Sold178.0K196.0K221.0K302.0K
 
 
 
 
 
Depreciation And Amortization37.0K39.0K37.0K--
 
 
 
 
 
Operating ExpensesGross Income5.6M7.0M8.8M9.8M
 
 
 
 
 
General Expenses12.2M12.2M11.8M13.8M
 
 
 
 
 
Research And Development4.3M3.0M3.8M4.4M
 
 
 
 
 
Total Operating Expenses12.4M12.4M12.1M14.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.6M-5.1M-3.1M-4.0M
 
 
 
 
 
Interest Expense On Debt935.0K895.0K800.0K800.0K
 
 
 
 
 
Other Expenses-36.0K-8.0K-18.0K--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.6M-6.0M-3.9M-4.8M
 
 
 
 
 
Net Income-7.6M-6.0M-3.9M-4.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS101.0M101.1M101.3M101.9M
 
 
 
 
 
Shares To Calculate EPS Diluted101.0M101.1M101.3M101.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.06-$0.04-$0.05
 
 
 
 
 
EPS Diluted-$0.07-$0.06-$0.04-$0.05
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account